Sight Sciences (SGHT)
(Delayed Data from NSDQ)
$6.76 USD
+0.44 (6.96%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $6.78 +0.02 (0.30%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Income Statements
Fiscal Year end for Sight Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 81 | 71 | 49 | 28 | NA |
Cost Of Goods | 12 | 12 | 9 | 9 | NA |
Gross Profit | 69 | 59 | 40 | 18 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 126 | 143 | 92 | 51 | 0 |
Income After Depreciation & Amortization | -57 | -84 | -51 | -32 | 0 |
Non-Operating Income | 7 | 2 | -7 | 0 | NA |
Interest Expense | 5 | 4 | 4 | 2 | NA |
Pretax Income | -55 | -86 | -63 | -35 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -56 | -86 | -63 | -35 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -56 | -86 | -63 | -35 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -56 | -83 | -50 | -31 | 0 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | NA |
Income After Depreciation & Amortization | -57 | -84 | -51 | -32 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 48.63 | 47.85 | 26.73 | NA | NA |
Diluted EPS Before Non-Recurring Items | -1.14 | -1.80 | -2.36 | NA | NA |
Diluted Net EPS (GAAP) | -1.14 | -1.80 | -2.36 | NA | NA |
Fiscal Year end for Sight Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 21.37 | 19.27 | 18.75 | 20.01 | 23.47 |
Cost Of Goods | 3.03 | 2.79 | 2.77 | 2.68 | 3.38 |
Gross Profit | 18.35 | 16.47 | 15.98 | 17.33 | 20.09 |
SG&A, R&D, and Dept/Amort Expenses | 31.00 | 31.20 | 27.09 | 30.74 | 35.28 |
Income After SG&A, R&D, and Dept/Amort Expenses | -12.65 | -14.73 | -11.11 | -13.41 | -15.19 |
Non-Operating Income | 1.48 | -0.32 | 1.78 | 1.89 | 1.79 |
Interest Expense | 1.15 | 1.20 | 1.35 | 1.43 | 1.35 |
Pretax Income | -12.31 | -16.25 | -10.68 | -12.96 | -14.75 |
Income Taxes | 0.02 | 0.02 | 0.01 | 0.08 | 0.01 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -12.33 | -16.27 | -10.69 | -13.04 | -14.75 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -12.33 | -16.27 | -10.69 | -13.04 | -14.75 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 49.90 | 49.49 | 48.90 | 48.67 | 48.54 |
Diluted EPS Before Non-Recurring Items | -0.25 | -0.33 | -0.22 | -0.27 | -0.30 |
Diluted Net EPS (GAAP) | -0.25 | -0.33 | -0.22 | -0.27 | -0.30 |